综述

耶氏肺孢子菌基因分型研究进展

  • 薛婷 ,
  • 杜伟勤
展开
  • 1 国家卫健委尘肺病重点实验室,呼吸疾病防治与基础研究山西省重点实验室,山西医科大学第一医院呼吸与危重症医学科,太原 030001
    2 山西省吕梁市人民医院医学检验科,吕梁 033000
薛婷(1988-),女,博士,讲师,从事病原微生物感染及相关机制研究。E-mail: beyondtinger@126.com
* 薛婷,E-mail: beyondtinger@126.com

收稿日期: 2021-05-14

  修回日期: 2021-08-16

  网络出版日期: 2021-12-15

基金资助

山西省自然科学基金基础研究计划项目(20210302124039);山西省高等学校科技创新项目(2020L0201);山西省高等学校科技创新项目(2020L0223);山西医科大学省级博士基金(SD1905);山西医科大学校级博士启动基金(XD1905)

Progress in genotyping of Pneumocystis jirovecii

  • Ting XUE ,
  • Wei-qin DU
Expand
  • 1 National Health Commission Key Laboratory of Pneumoconiosis, Key Laboratory of Prophylaxis and Treatment and Basic Research for Respiratory Diseases of Shanxi Province, Department of Respiratory and Critical Medicine, the First Hospital of Shanxi Medical University, Taiyuan 030001, China
    2 Department of Clinical Laboratory, the People's Hospital of Lvliang, Lvliang 033000, China

Received date: 2021-05-14

  Revised date: 2021-08-16

  Online published: 2021-12-15

Supported by

Basic Research Projects of Natural Sciences in Shanxi Province(20210302124039);Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi(2020L0201);Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi(2020L0223);Start-up Foundation for Doctoral Scientific Research of Shanxi Province(SD1905);Start-up Foundation for Doctoral Scientific Research of Shanxi Medical University(XD1905)

摘要

耶氏肺孢子菌是一种可感染人的机会致病性真菌,可致严重的肺孢子菌肺炎,尤其见于免疫功能低下者。肺孢子菌最初被认为是一种原虫,命名为卡氏肺孢子虫。20世纪80年代末,运用分子生物学技术对其基因序列进行检测分析,证实肺孢子虫是一种非典型真菌。由于缺乏有效的体外培养体系,很难清楚地了解肺孢子菌的病原生物学特性和流行病学特征。随着分子生物学技术的广泛应用,耶氏肺孢子菌分子分型的方法近年来得到了全面发展和研究,然而其基因分型方案缺乏国际标准化和全球共识,致使耶氏肺孢子菌临床分离株的流行病学及种群结构、传染源追溯、传播特性以及肺孢子菌肺炎的发病机制和防治等研究受到阻碍。为纪念耶氏肺孢子菌更名20周年,本文就其基因分型的研究进展进行综述。

本文引用格式

薛婷 , 杜伟勤 . 耶氏肺孢子菌基因分型研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2021 , 39(6) : 842 -847 . DOI: 10.12140/j.issn.1000-7423.2021.06.018

Abstract

Pneumocystis jirovecii, an opportunistic pathogenic fungus, may cause severe pneumocystis pneumonia (PCP), especially in immunodeficient patients. Pneumocystis was initially classified as a protozoan, named P. carinii. However, it was phylogenetically reclassified as an atypical fungal pathogen at late 1980s, which was confirmed with genetic sequence analyses, using molecular biology techniques. Due to lack of in vitro culture method, it has been difficult to clearly understand the patho-biological and epidemiological characteristics of Pneumocystis. With the wide application of molecular biology techniques, genotyping method for Pneumocystis has been extensively developed in recent years, however, no international standardization and global consensus on the genotyping scheme has been reached, hindering the investigation of epidemiology, population structure, source of infection, transmission characteristics of the clinical isolate of P. jirovecii, and in turn impeding the studies on the pathogenesis and control strategy of PCP. This review summarizes the progress in research on the genotyping approaches for P. jirovecii, in commemorating the 20th anniversary of its renaming.

参考文献

[1] Dunbar A, Schauwvlieghe A, Algoe S, et al. Epidemiology of Pneumocystis jirovecii pneumonia and (non-) use of prophylaxis[J]. Front Cell Infect Microbiol, 2020, 10: 224.
[2] Lum J, Echenique I, Athans V, et al. Alternative pneumocystis prophylaxis in solid organ transplant recipients at two large transplant centers[J]. Transpl Infect Dis, 2021, 23(1): e13461.
[3] Edman JC, Kovacs JA, Masur H, et al. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi[J]. Nature, 1988, 334(6182): 519-522.
[4] Hibbett DS, Binder M, Bischoff JF, et al. A higher-level phylogenetic classification of the Fungi[J]. Mycol Res, 2007, 111(5): 509-547.
[5] Shah JS, Pieciak W, Liu J, et al. Diversity of host species and strains of Pneumocystis carinii is based on rRNA sequences[J]. Clin Diagn Lab Immunol, 1996, 3(1): 119-127.
[6] Wakefield AE, Fritscher CC, Malin AS, et al. Genetic diversity in human-derived Pneumocystis carinii isolates from four geographical locations shown by analysis of mitochondrial rRNA gene sequences[J]. J Clin Microbiol, 1994, 32(12): 2959-2961.
[7] Demanche C, Berthelemy M, Petit T, et al. Phylogeny of Pneumocystis carinii from 18 primate species confirms host specificity and suggests coevolution[J]. J Clin Microbiol, 2001, 39(6): 2126-2133.
[8] Guillot J, Demanche C, Hugot JP, et al. Parallel phylogenies of Pneumocystis species and their mammalian hosts[J]. J Eukaryot Microbiol, 2001, Suppl: 113-115.
[9] Ma L, Cisse OH, Kovacs JA. A molecular window into the biology and epidemiology of Pneumocystis spp.[J]. Clin Microbiol Rev, 2018, 31(3).
[10] Lee CH, Helweg-Larsen J, Tang X, et al. Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes[J]. J Clin Microbiol, 1998, 36(3): 734-741.
[11] Nimri LF, Moura IN, Huang L, et al. Genetic diversity of Pneumocystis carinii f. sp. hominis based on variations in nucleotide sequences of internal transcribed spacers of rRNA genes[J]. J Clin Microbiol, 2002, 40(4): 1146-1151.
[12] Robberts FJ, Liebowitz LD, Chalkley LJ. Genotyping and coalescent phylogenetic analysis of Pneumocystis jiroveci from South Africa[J]. J Clin Microbiol, 2004, 42(4): 1505-1510.
[13] Helweg-Larsen J, Lee CH, Jin S, et al. Clinical correlation of variations in the internal transcribed spacer regions of rRNA genes in Pneumocystis carinii f. sp. hominis[J]. Aids, 2001, 15(4): 451-459.
[14] Beser J, Botero-Kleiven S, Lebbad M, et al. A limited number of ITS haplotypes defines the diversity of Pneumocystis jirovecii strains in Sweden[J]. Infect Genet Evol, 2011, 11(5): 948-954.
[15] van Hal SJ, Gilgado F, Doyle T, et al. Clinical significance and phylogenetic relationship of novel Australian Pneumocystis jirovecii genotypes[J]. J Clin Microbiol, 2009, 47(6): 1818-1823.
[16] Matsumura Y, Shindo Y, Iinuma Y, et al. Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes[J]. BMC Infect Dis, 2011, 11: 76.
[17] Li K, He A, Cai WP, et al. Genotyping of Pneumocystis jirovecii isolates from chinese HIV-infected patients based on nucleotide sequence variations in the internal transcribed spacer regions of rRNA genes[J]. Med Mycol, 2013, 51(1): 108-112.
[18] Sun L, Huang M, Wang J, et al. Genotyping of Pneumocystis jirovecii isolates from human immunodeficiency virus-negative patients in China[J]. Infect Genet Evol, 2015, 31: 209-215.
[19] Xue T, Ma Z, Liu F, et al. Genotyping of Pneumocystis jirovecii by use of a new simplified nomenclature system based on the internal transcribed spacer regions and 5.8S rRNA gene of the rRNA operon[J]. J Clin Microbiol, 2019, 57(6).
[20] Valero C, Buitrago MJ, Gits-Muselli M, et al. Copy number variation of mitochondrial dna genes in Pneumocystis jirovecii according to the fungal load in BAL specimens[J]. Front Microbiol, 2016, 7: 1413.
[21] Alanio A, Gits-Muselli M, Mercier-Delarue S, et al. Diversity of Pneumocystis jirovecii during infection revealed by ultra-deep pyrosequencing[J]. Front Microbiol, 2016, 7: 733.
[22] Ma L, Huang DW, Cuomo CA, et al. Sequencing and characterization of the complete mitochondrial genomes of three Pneumocystis species provide new insights into divergence between human and rodent Pneumocystis[J]. FASEB J, 2013, 27(5): 1962-1972.
[23] Schmoldt S, Schuhegger R, Wendler T, et al. Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantation[J]. J Clin Microbiol, 2008, 46(3): 966-971.
[24] Esteves F, Gaspar J, Tavares A, et al. Population structure of Pneumocystis jirovecii isolated from immunodeficiency virus-positive patients[J]. Infect Genet Evol, 2010, 10(2): 192-199.
[25] Morilla R, Gonzalez-Magana A, Friaza V, et al. Genetic polymorphisms of superoxide dismutase locus of Pneumocystis jirovecii in Spanish population[J]. Front Public Health, 2019, 7: 292.
[26] Nahimana A, Francioli P, Blanc DS, et al. Determination of the copy number of the nuclear rDNA and beta-tubulin genes of Pneumocystis carinii f. sp. hominis using PCR multicompetitors[J]. J Eukaryot Microbiol, 2000, 47(4): 368-372.
[27] Edlind TD, Bartlett MS, Weinberg GA, et al. The beta-tubulin gene from rat and human isolates of Pneumocystis carinii[J]. Mol Microbiol, 1992, 6(22): 3365-3373.
[28] Volpe G, Sbaiz L, Avanzini C, et al. Genetic diversity of Pneumocystis carinii isolated from human immunodeficiency virus-positive patients in Turin, Italy[J]. J Clin Microbiol, 2001, 39(8): 2995-2998.
[29] Hauser PM, Francioli P, Bille J, et al. Typing of Pneumocystis carinii sp. f. hominis by PCR-SSCP of four genomic regions[J]. J Eukaryot Microbiol, 1997, 44(6): 16S.
[30] Pasic L, Goterris L, Guerrero-Murillo M, et al. Consensus multilocus sequence typing scheme for Pneumocystis jirovecii[J]. J Fungi, 2020, 6(4).
[31] Miller RF, Lindley AR, Copas A, et al. Genotypic variation in Pneumocystis jirovecii isolates in Britain[J]. Thorax, 2005, 60(8): 679-682.
[32] Miller RF, Lindley AR, Malin AS, et al. Isolates of Pneumocystis jirovecii from Harare show high genotypic similarity to isolates from London at the superoxide dismutase locus[J]. Trans R Soc Trop Med Hyg, 2005, 99(3): 202-206.
[33] Huang L, Crothers K, Atzori C, et al. Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance[J]. Emerg Infect Dis, 2004, 10(10): 1721-1728.
[34] Rabodonirina M, Vaillant L, Taffe P, et al. Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia[J]. Emerg Infect Dis, 2013, 19(1): 21-28.
[35] Ripamonti C, Orenstein A, Kutty G, et al. Restriction fragment length polymorphism typing demonstrates substantial diversity among Pneumocystis jirovecii isolates[J]. J Infect Dis, 2009, 200(10): 1616-1622.
[36] Narayanan S. Applications of restriction fragment length polymorphism[J]. Ann Clin Lab Sci, 1991, 21(4): 291-296.
[37] Ma L, Kovacs JA. Rapid detection of mutations in the human-derived Pneumocystis carinii dihydropteroate synthase gene associated with sulfa resistance[J]. Antimicrob Agents Chemother, 2001, 45(3): 776-780.
[38] Ma L, Kovacs JA, Cargnel A, et al. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis[J]. J Infect Dis, 2002, 185(10): 1530-1532.
[39] Hauser PM, Blanc DS, Sudre P, et al. Genetic diversity of Pneumocystis carinii in HIV-positive and -negative patients as revealed by PCR-SSCP typing[J]. Aids, 2001, 15(4): 461-466.
[40] Ma L, Kutty G, Jia Q, et al. Analysis of variation in tandem repeats in the intron of the major surface glycoprotein expression site of the human form of Pneumocystis carinii[J]. J Infect Dis, 2002, 186(11): 1647-1654.
[41] Gupta R, Mirdha BR, Guleria R, et al. Genetic characterization of UCS region of Pneumocystis jirovecii and construction of allelic profiles of Indian isolates based on sequence typing at three regions[J]. Infect Genet Evol, 2013, 13: 180-186.
[42] Jarboui MA, Mseddi F, Sellami H, et al. Genetic diversity of Pneumocystis jirovecii strains based on sequence variation of different DNA region[J]. Med Mycol, 2013, 51(6): 561-567.
[43] Esteves F, Tavares A, Costa MC, et al. Genetic characterization of the UCS and Kex1 loci of Pneumocystis jirovecii[J]. Eur J Clin Microbiol Infect Dis, 2009, 28(2): 175-178.
[44] Ma L, Chen Z, Huang da W, et al. Genome analysis of three Pneumocystis species reveals adaptation mechanisms to life exclusively in mammalian hosts[J]. Nat Commun, 2016, 7: 10740.
[45] Parobek CM, Jiang LY, Patel JC, et al. Multilocus microsatellite genotyping array for investigation of genetic epidemiology of Pneumocystis jirovecii[J]. J Clin Microbiol, 2014, 52(5): 1391-1399.
[46] Gits-Muselli M, Peraldi MN, de Castro N, et al. New short tandem repeat-based molecular typing method for Pneumocystis jirovecii reveals intrahospital transmission between patients from different wards[J]. PLoS One, 2015, 10(5): e0125763.
[47] Cisse OH, Pagni M, Hauser PM. De novo assembly of the Pneumocystis jirovecii genome from a single bronchoalveolar lavage fluid specimen from a patient[J]. mBio, 2012, 4(1): e00428-00412.
[48] Chan JZ, Pallen MJ, Oppenheim B, et al. Genome sequencing in clinical microbiology[J]. Nat Biotechnol, 2012, 30(11): 1068-1071.
文章导航

/

〈 〉